• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋海绵和细菌作为用于药理学应用的酶抑制剂的具有挑战性的来源。

Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.

作者信息

Ruocco Nadia, Costantini Susan, Palumbo Flora, Costantini Maria

机构信息

Department of Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Napoli, Italy.

Department of Biology, University of Naples Federico II, Complesso Universitario di Monte Sant'Angelo, Via Cinthia, 80126 Napoli, Italy.

出版信息

Mar Drugs. 2017 Jun 12;15(6):173. doi: 10.3390/md15060173.

DOI:10.3390/md15060173
PMID:28604647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5484123/
Abstract

Enzymes play key roles in different cellular processes, for example, in signal transduction, cell differentiation and proliferation, metabolic processes, DNA damage repair, apoptosis, and response to stress. A deregulation of enzymes has been considered one of the first causes of several diseases, including cancers. In the last several years, enzyme inhibitors, being good candidates as drugs in the pathogenic processes, have received an increasing amount of attention for their potential application in pharmacology. The marine environment is considered a challenging source of enzyme inhibitors for pharmacological applications. In this review, we report on secondary metabolites with enzyme inhibitory activity, focusing our attention on marine sponges and bacteria as promising sources. In the case of sponges, we only reported the kinase inhibitors, because this class was the most representative isolated so far from these marine organisms.

摘要

酶在不同的细胞过程中发挥着关键作用,例如在信号转导、细胞分化与增殖、代谢过程、DNA损伤修复、细胞凋亡以及应激反应中。酶的失调被认为是包括癌症在内的多种疾病的首要病因之一。在过去几年中,酶抑制剂作为致病过程中药物的良好候选者,因其在药理学中的潜在应用而受到越来越多的关注。海洋环境被认为是用于药理学应用的酶抑制剂的一个具有挑战性的来源。在本综述中,我们报道了具有酶抑制活性的次生代谢产物,重点关注海洋海绵和细菌这两个有前景的来源。就海绵而言,我们仅报道了激酶抑制剂,因为此类是迄今为止从这些海洋生物中分离出的最具代表性的一类。

相似文献

1
Marine Sponges and Bacteria as Challenging Sources of Enzyme Inhibitors for Pharmacological Applications.海洋海绵和细菌作为用于药理学应用的酶抑制剂的具有挑战性的来源。
Mar Drugs. 2017 Jun 12;15(6):173. doi: 10.3390/md15060173.
2
Biological and Chemical Diversity of Marine Sponge-Derived Microorganisms over the Last Two Decades from 1998 to 2017.海洋海绵源微生物近二十年来(1998 年至 2017 年)的生物和化学成分多样性。
Molecules. 2020 Feb 14;25(4):853. doi: 10.3390/molecules25040853.
3
A Perspective on Enzyme Inhibitors from Marine Organisms.从海洋生物看酶抑制剂。
Mar Drugs. 2020 Aug 19;18(9):431. doi: 10.3390/md18090431.
4
First Report on Chitin in a Non-Verongiid Marine Demosponge: The Mycale euplectellioides Case.首个关于非偕老同穴类海洋寻常海绵中几丁质的报道:指花海绵属案例。
Mar Drugs. 2018 Feb 20;16(2):68. doi: 10.3390/md16020068.
5
Insights into the lifestyle of uncultured bacterial natural product factories associated with marine sponges.对与海洋海绵相关的未培养细菌天然产物工厂生活方式的见解。
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E347-E356. doi: 10.1073/pnas.1616234114. Epub 2017 Jan 3.
6
Bioactive compounds from marine sponges and their symbiotic microbes: a potential source of nutraceuticals.来自海洋海绵及其共生微生物的生物活性化合物:营养保健品的潜在来源。
Adv Food Nutr Res. 2012;65:137-51. doi: 10.1016/B978-0-12-416003-3.00008-1.
7
Biotechnological Applications of Marine Enzymes From Algae, Bacteria, Fungi, and Sponges.藻类、细菌、真菌和海绵体来源的海洋酶的生物技术应用
Adv Food Nutr Res. 2017;80:75-106. doi: 10.1016/bs.afnr.2016.10.005. Epub 2016 Dec 29.
8
Diversity and biotechnological potential of the sponge-associated microbial consortia.海绵相关微生物群落的多样性及生物技术潜力
J Ind Microbiol Biotechnol. 2006 Jul;33(7):545-51. doi: 10.1007/s10295-006-0123-2. Epub 2006 Apr 22.
9
Marine sponges: potential sources of new antimicrobial drugs.海洋海绵:新型抗菌药物的潜在来源。
Curr Pharm Biotechnol. 2009 Jan;10(1):86-105. doi: 10.2174/138920109787048625.
10
Integrin triplets of marine sponges in human D2 receptor heteromers.人类D2受体异聚体中海洋海绵的整合素三联体。
J Recept Signal Transduct Res. 2012 Aug;32(4):202-8. doi: 10.3109/10799893.2012.692119. Epub 2012 Jun 20.

引用本文的文献

1
Chromatographic Analysis and Enzyme Inhibition Potential of Houtt.: Computational Docking, ADME, Pharmacokinetic, and Toxicokinetic Analyses of the Major Compounds.鱼腥草的色谱分析及酶抑制潜力:主要化合物的计算对接、ADME、药代动力学和毒代动力学分析
Pharmaceuticals (Basel). 2025 Mar 14;18(3):408. doi: 10.3390/ph18030408.
2
Converging frontiers in cancer treatment: the role of nanomaterials, mesenchymal stem cells, and microbial agents-challenges and limitations.癌症治疗中的前沿融合:纳米材料、间充质干细胞和微生物制剂的作用——挑战与局限
Discov Oncol. 2024 Dec 21;15(1):818. doi: 10.1007/s12672-024-01590-0.
3
Enzyme Inhibitors from Gorgonians and Soft Corals.

本文引用的文献

1
Marine natural products.海洋天然产物。
Nat Prod Rep. 2016 Mar;33(3):382-431. doi: 10.1039/c5np00156k. Epub 2016 Feb 3.
2
Emerging concepts promising new horizons for marine biodiscovery and synthetic biology.新兴概念为海洋生物发现和合成生物学带来了新的前景。
Mar Drugs. 2015 May 13;13(5):2924-54. doi: 10.3390/md13052924.
3
Marine natural products.海洋天然产物。
海葵和软珊瑚中的酶抑制剂。
Mar Drugs. 2023 Jan 31;21(2):104. doi: 10.3390/md21020104.
4
Structure-Activity Relationship of Cytotoxic Natural Products from Indonesian Marine Sponges.印度尼西亚海洋海绵细胞毒性天然产物的构效关系
Rev Bras Farmacogn. 2022;32(1):12-38. doi: 10.1007/s43450-021-00195-w. Epub 2022 Jan 7.
5
Effects of Sponge-Derived Alkaloids on Activities of the Bacterial α-D-Galactosidase and Human Cancer Cell α-N-Acetylgalactosaminidase.海绵源生物碱对细菌α-D-半乳糖苷酶和人癌细胞α-N-乙酰半乳糖胺酶活性的影响。
Biomedicines. 2021 May 5;9(5):510. doi: 10.3390/biomedicines9050510.
6
The preparation of (4H)-imidazol-4-ones and their application in the total synthesis of natural products.(4H)-咪唑-4-酮的制备及其在天然产物全合成中的应用。
Org Chem Front. 2020 Oct 21;7(20):3284-3311. doi: 10.1039/d0qo00764a. Epub 2020 Aug 26.
7
Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge sp.奥西里斯因 G-I,来自马约特海洋海绵 sp.的新长链高度氧化聚乙炔
Mar Drugs. 2020 Jul 3;18(7):350. doi: 10.3390/md18070350.
8
Exploring the Antiangiogenic Potential of Solomonamide A Bioactive Precursors: In Vitro in Vivo Evidences of the Inhibitory Activity of Solo F-OH During Angiogenesis.探索 Solomonamide A 生物活性前体的抗血管生成潜力:体外和体内证据表明 Solo F-OH 在血管生成过程中的抑制活性。
Mar Drugs. 2019 Apr 15;17(4):228. doi: 10.3390/md17040228.
9
Effect of Pentacyclic Guanidine Alkaloids from the Sponge on Activity of α-Glycosidases from Marine Bacteria.海绵来源五环胍类生物碱对海洋细菌α-糖苷酶活性的影响。
Mar Drugs. 2019 Jan 1;17(1):22. doi: 10.3390/md17010022.
10
Natural Peptides in Drug Discovery Targeting Acetylcholinesterase.天然肽类在乙酰胆碱酯酶靶点药物研发中的应用
Molecules. 2018 Sep 13;23(9):2344. doi: 10.3390/molecules23092344.
Nat Prod Rep. 2015 Feb;32(2):116-211. doi: 10.1039/c4np00144c.
4
Cyclin-dependent kinase inhibitors as marketed anticancer drugs: where are we now? A short survey.作为上市抗癌药物的细胞周期蛋白依赖性激酶抑制剂:我们目前处于什么阶段?一项简短调查。
Molecules. 2014 Sep 11;19(9):14366-82. doi: 10.3390/molecules190914366.
5
Marine sponge derived natural products between 2001 and 2010: trends and opportunities for discovery of bioactives.2001年至2010年期间从海洋海绵中提取的天然产物:生物活性物质发现的趋势与机遇
Mar Drugs. 2014 Aug 19;12(8):4539-77. doi: 10.3390/md12084539.
6
Marine natural products.海洋天然产物。
Nat Prod Rep. 2014 Jan 17;31(2):160-258. doi: 10.1039/c3np70117d.
7
The human kinome and kinase inhibition.人类激酶组与激酶抑制作用
Curr Protoc Pharmacol. 2013 Mar;Chapter 2:Unit2.9. doi: 10.1002/0471141755.ph0209s60.
8
Marine natural products.海洋天然产物。
Nat Prod Rep. 2013 Feb;30(2):237-323. doi: 10.1039/c2np20112g.
9
Marine natural products.海洋天然产物。
Nat Prod Rep. 2012 Feb;29(2):144-222. doi: 10.1039/c2np00090c. Epub 2011 Dec 22.
10
Kinase inhibitors from marine sponges.海洋海绵来源的激酶抑制剂。
Mar Drugs. 2011;9(10):2131-2154. doi: 10.3390/md9102131. Epub 2011 Oct 24.